Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P. Peet

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Biochemistry|February 4, 1997
Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moietyJ A Malikayil, J P Burkhart, H A Schreuder, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
The design and synthesis of purine inhibitors of CDK2. IIIP W Shum, N P Peet, P M Weintraub, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Biochemistry|February 4, 1997
Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moietyJ A Malikayil, J P Burkhart, H A Schreuder, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
The design and synthesis of purine inhibitors of CDK2. IIIP W Shum, N P Peet, P M Weintraub, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
Pageof 4